Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2022-10-31 00:00:00 ET · period of report 2022-10-27 · accession 0000899243-22-034543 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-31 | 2022-10-27+ | BDTX | BB BIOTECH AG | 10% | P - Purchase | $2.02 | +364.7K | 5.28M | +7% | +$735.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-27 | P | A | 191,678 | $1.87 | 5,105,064 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-28 | P | A | 172,974 | $2.18 | 5,278,038 | D | — | — |